The News Craving
Published by
Reuters
Reuters
By Carl O’Donnell and Manas Mishra (Reuters) -The U.S. drug regulator on Monday granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine that had earned emergency-use authorization in December, making it the first to secure such Food and Drug Administration validation as health authorities struggle to win over vaccine skeptics. The FDA approved the two-dose vaccine for use in people age 16 and older. Public health officials hope the action will convince more unvaccinated Americans that Pfizer’s shot is safe and effective. Vaccine hesitancy among some Americans has hindered the U.S….